Ex-vivo Delivery of Rituximab to Prevent PTLD in EBV Mismatch Lung Transplant Recipients: A Pilot Trial

Clinical trial NCT04507477 · UNKNOWN

Trial details

NCT number: NCT04507477
Sponsor: University Health Network, Toronto
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Epstein-Barr Virus Infections Post-transplant Lymphoproliferative Disorder

Start date: 2020-07-07
Primary completion: 2022-12-07
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.